Skip to main content
Covid-19 second wave in Mumbai, India.
War in Gaza:: find out how we're responding
Learn more
We fill gaps in India’s health system and provide specific medical care to neglected people who would otherwise struggle to access it.

We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address specific healthcare needs and emerging public health concerns.

We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.

Key activities

Our activities in 2022 in India

Data and information from the International Activity Report 2022.

MSF in India in 2022 In India, Médecins Sans Frontières (MSF) continued to provide treatment for patients living with drug-resistant tuberculosis (DR-TB) and HIV, and medical and psychological care for people affected by conflict and violence.
India IAR map 2022

In the capital, New Delhi, we run a clinic for victims of sexual and gender-based violence, offering round-the-clock care. In December, we organised a national-level symposium calling for better access to medical and psychological care for victims.

Throughout the year, we provided mental health and psychosocial support to people affected by the conflict in Kashmir, and ran mobile clinics offering basic healthcare to communities in remote areas of Chhattisgarh.

In Mumbai, MSF’s clinic focuses on treating complex cases of DR-TB, including extensively drug-resistant forms of the disease, with innovative drug combinations. For children under five, we implement all-oral regimens, thereby avoiding the need for painful injections.

In addition, we are working with the National Tuberculosis Elimination Programme and Municipal Corporation of Greater Mumbai to reduce the high TB incidence and death rates in the area. Our team co-manages a DR-TB centre in a public hospital, and we support diagnosis, treatment, counselling, health promotion and follow-up in general healthcare facilities.

In 2022, we also continued treating patients enrolled in the endTB clinical trial, with the aim of generating more evidence for shorter, more tolerable, injection-free treatments for multidrug-resistant TB.

Our project in Manipur implements a person-centred care approach for people living with HIV, TB, DR-TB and hepatitis C. We transferred many of our stable HIV patients to Ministry of Health facilities, enabling us to focus on those with co-infections and complications. We also run a one-stop care centre offering comprehensive services for intravenous drug users.

In one of India’s poorest states, Bihar, we provide both lifesaving and palliative care to patients living with advanced HIV.

Our toll-free telemedicine helpline supports diabetes patients to manage their condition. India has the second-highest burden of diabetes globally, and the prevention and management of the disease, as well as its associated complications, remain a huge challenge.

 

In 2022
Kala azar-HIV co-infection in Bihar, Animated explainer | ENG
video

Explaining kala azar-HIV co-infection

Have you heard of kala azar?

Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.

This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

 
2018 Union Conference - Johnson & Johnson (J&J) protest
Access to medicines

TB activists challenge patent in India, in bid to prevent J&J from extending monopoly

Press Release 8 Feb 2019
 
Key populations, peer-led HIV and SRH services
HIV/AIDS

Meeting the specific needs of key populations living with HIV

Project Update 23 Jul 2018
 
Treating Severe Acute Malnutrition in Chakradharpur block of Jharkhand
Website

India Activity Report 2017

msfindia.in
 
Free Hepatitis clinic in Meerut
Photo Story

One year, 1,198 patients

2 Mar 2018
Photo Story
 
Access to Healthcare

Unmerited Pfizer patent on pneumonia vaccine limits access for children

Press Release 20 Nov 2017
 
India, Asansol project. Antibiotic resistance
Antibiotic resistance

Drug-resistant infections are a looming challenge around the world

Project Update 16 Nov 2017
 
Nonyanyiso Baloi - MSF Treatment For TB in South Africa.
Access to medicines

MSF reports on use of the new tuberculosis drugs bedaquiline and delamanid

Press Release 25 Oct 2016
 
MSF TB Treatment in Mumbai, India
Photo Story

"Providing comprehensive treatment for patients with tuberculosis"

25 Oct 2016
Photo Story
 
Guinea-Bissau. New healthcare project for children in Bafata
Child health

"Transferring medicine from rich countries to poor countries without adapting it does not always work"

Voices from the Field 22 Sep 2016
 
India

Kashmir unrest one-month update - MSF donates external fixators for trauma victims, continues psychological first aid

Project Update 9 Aug 2016
 
India

MSF calls for affordable pneumonia vaccines ahead of Pfizer’s patent hearing in India

Press Release 28 Jul 2016
 
India

Access Campaign: New threat against affordable medicines in trade negotiations with India and ASEAN

Press Release 21 Apr 2016

Contact us

Treating kala azar-HIV co-infection in Bihar, India
MSF India

5th Floor, Okhla NSIC Metro Station Building
New Delhi – 110020
India